Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...
Transcriptional silencing of dual specificity phosphatase type 2 (DUSP2) abrogates drug-induced apoptosis and predicts cisplatin resistance in head and neck squamous carcinomas No significant ...
Researchers at Purdue University have developed a new type of cancer therapy that uses a modified microRNA, miR-34a, to block cancer cell division. In preclinical tests in mice, treatment using the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results